3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Thoracic
1
Other solid neoplasm
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
5
Mesothelioma, Malignant
2
Pancreatic Neoplasms
1
Myelodysplastic Syndromes
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Glioblastoma
1
COVID-19
1
Adenocarcinoma of Lung
1
Interventions
Azacitidine
4
Nivolumab
2
sargramostim
1
ruxolitinib
1
rucaparib
1
incomplete Freund's adjuvant
1
cc-486
1
bemcentinib
1
abiraterone
1
Tretinoin
1
TTI-621
1
Standard of Care
1
Rituximab
1
Radiotherapy
1
Practice Guidelines as Topic
1
Polymerase Chain Reaction
1
Palliative Care
1
Paclitaxel
1
Methylprednisolone
1
Melphalan
1
Injections
1
Immunoenzyme Techniques
1
INCB059872
1
INCB057643
1
Gemcitabine
1
Flow Cytometry
1
Cyclosporine
1
Cyclophosphamide
1
Cord Blood Stem Cell Transplantation
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
bemcentinib
×
Thoracic
×
Clear all
NCT06469138
2025-01-29
8479217
BerGenBio ASA
Phase 1
Completed
6 enrolled
17 charts